Recent Work
Circulating biomarkers are quickly becoming a crucial part of diagnosis and disease monitoring for physicians, researchers — and even some consumers.
Zebras and giraffes offer one another protection without food competition.
Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with fewer side effects.
A new tool predicts where proteins fit, opening new frontiers in drug discovery.
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
How a tissue-swelling method brought super-resolution imaging to the masses.
In response to cellular stress, proteins become ensnared in chemical traffic jams, creating a kind of widespread sluggishness scientists call “proteolethargy.”
The first example of fiber optics in nature could light the way for internet innovation.
Pulses of light and sound seem to have beneficial effects. But some argue it is too soon to market experimental devices.
The medication is the first in decades to have a different mode of action than do current drugs, achieving better symptom relief with fewer side effects.